View Full Paper

Owner Consent Verified
Research Proposal 4.7

Ethical Considerations in Digital Transformation for Pharmaceutical Firms: A Comparative Perspective

18
Pages
Chicago
Style
~ 19–28 mins
Reading Time
Data Privacy Sustainability Leadership
Abstract

This research proposal investigates “Ethical Considerations in Digital Transformation for Pharmaceutical Firms: A Comparative Perspective” using a mixed-methods case study. Through a economic lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.

Download PDF Order Similar Paper Save

Ethical Considerations in Digital Transformation for Pharmaceutical Firms: A Comparative Perspective

ABSTRACT
Ethical Considerations in Digital Transformation for Pharmaceutical Firms: A Comparative Perspective is unpacked across themes: risks, costs, scalability, and ethics. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
14 Pages 4.7
Quantum Computing for EU Startups: Market Entry Strategy | Evidence from South Asia
IoT Health Blockchain
View Paper
36 Pages 4.6
Governance And Risk in Renewable Energy for Healthcare Providers: A Comparative Perspective
AI AIOps HCI
View Paper
7 Pages 4.4
Human Factors And Usability in Public Health for City Planners: A Comparative Perspective
Metaverse HCI DevSecOps
View Paper